μ-opioid receptor antibody reveals tissue-dependent specific staining and increased neuronal μ-receptor immunoreactivity at the injured nerve trunk in mice

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Schmidt, Yvonne ^a   Gavériaux Ruff, Claire ^b,c   Machelska, Halina ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; MU OPIOID RECEPTOR ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; ANTIBODY SPECIFICITY; ARTICLE; CHRONIC CONSTRICTION INJURY; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NERVE INJURY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCIATIC NERVE INJURY; SPINAL GANGLION; TISSUE SPECIFICITY;

ANIMALS; ANTIBODIES; CELL LINE; GANGLIA, SPINAL; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; PAIN; PERIPHERAL NERVOUS SYSTEM DISEASES; RECEPTORS, OPIOID, MU; SCIATIC NERVE; SKIN;

EID: 84896739610     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079099     Document Type: Article

References (43)

1. Costigan M, Scholz J, Woolf CJ (2009) Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 32: 1-32.
2. Stein C, Reinecke H, Sorgatz H (2010) Opioid use in chronic noncancer pain: guidelines revisited. Curr Opin Anaesthesiol 23: 598-601.
3. Machelska H (2011) Control of neuropathic pain by immune cells and opioids. CNS Neurol Disord Drug Targets 10: 559-570.
4. Pertovaara A, Wei H (2001) Peripheral effects of morphine in neuropathic rats: role of sympathetic postganglionic nerve fibers. Eur J Pharmacol 429: 139-145. (Pubitemid 33043991)
5. Martinez V, Christensen D, Kayser V (2002) The glycine/NMDA receptor antagonist (+)-HA966 enhances the peripheral effect of morphine in neuropathic rats. Pain 99: 537-545. (Pubitemid 35291072)
6. Obara I, Makuch W, Spetea M, Schutz J, Schmidhammer H, et al. (2007) Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat. Eur J Pharmacol 558: 60-67. (Pubitemid 46328870)
7. Hervera A, Negrete R, Leanez S, Martin-Campos JM, Pol O (2011) Peripheral effects of morphine and expression of mu-opioid receptors in the dorsal root ganglia during neuropathic pain: nitric oxide signaling. Mol Pain 7: 25.
8. Kabli N, Cahill CM (2007) Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain. Pain 127: 84-93. (Pubitemid 44959432)
9. Aley KO, Levine JD (2002) Different peripheral mechanisms mediate enhanced nociception in metabolic/toxic and traumatic painful peripheral neuropathies in the rat. Neuroscience 111: 389-397. (Pubitemid 34449699)
10. Cunha TM, Roman-Campos D, Lotufo CM, Duarte HL, Souza GR, et al. (2010) Morphine peripheral analgesia depends on activation of the PI3K-Peripheral gamma/AKT/nNOS/NO/KATP signaling pathway. Proc Natl Acad Sci U S A 107: 4442-4447.
11. Rashid MH, Inoue M, Toda K, Ueda H (2004) Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain. J Pharmacol Exp Ther 309: 380-387. (Pubitemid 38393151)
12. Uchida H, Ma L, Ueda H (2010) Epigenetic gene silencing underlies C-fiber dysfunctions in neuropathic pain. J Neurosci 30: 4806-4814.
13. Labuz D, Schmidt Y, Schreiter A, Rittner HL, Mousa SA, et al. (2009) Immune cell-derived opioids protect against neuropathic pain in mice. J Clin Invest 119: 278-286.
14. Labuz D, Schreiter A, Schmidt Y, Brack A, Machelska H (2010) T lymphocytes containing beta-endorphin ameliorate mechanical hypersensitivity following nerve injury. Brain Behav Immun 24: 1045-1053.
15. Truong W, Cheng C, Xu QG, Li XQ, Zochodne DW (2003) Mu opioid receptors and analgesia at the site of a peripheral nerve injury. Ann Neurol 53: 366-375. (Pubitemid 36258640)
16. Kolesnikov Y, El-Maarouf A, Rutishauser U, Pasternak G (2007) Reorganization of dorsal root ganglion neurons following chronic sciatic nerve constriction injury: correlation with morphine and lidocaine analgesia. Eur J Pharmacol 568: 124-133. (Pubitemid 46976896)
17. Lee CY, Perez FM, Wang W, Guan X, Zhao X, et al. (2011) Dynamic temporal and spatial regulation of mu opioid receptor expression in primary afferent neurons following spinal nerve injury. Eur J Pain 15: 669-675.
18. Zhang X, Bao L, Shi TJ, Ju G, Elde R, et al. (1998) Down-regulation of muopioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy. Neuroscience 82: 223-240.
19. Kohno T, Ji RR, Ito N, Allchorne AJ, Befort K, et al. (2005) Peripheral axonal injury results in reduced mu opioid receptor pre- and post-synaptic action in the spinal cord. Pain 117: 77-87. (Pubitemid 41764774)
20. Walczak JS, Pichette V, Leblond F, Desbiens K, Beaulieu P (2005) Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: a new model of neuropathic pain. Neuroscience 132: 1093-1102. (Pubitemid 40602543)
21. Walczak JS, Pichette V, Leblond F, Desbiens K, Beaulieu P (2006) Characterization of chronic constriction of the saphenous nerve, a model of neuropathic pain in mice showing rapid molecular and electrophysiological changes. J Neurosci Res 83: 1310-1322. (Pubitemid 43668014)
22. Scherrer G, Imamachi N, Cao YQ, Contet C, Mennicken F, et al. (2009) Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell 137: 1148-1159.
23. Niwa H, Rowbotham DJ, Lambert DG (2012) Evaluation of primary opioid receptor antibodies for use in western blotting. Br J Anaesth 108: 530-532.
24. Scherrer G, Tryoen-Toth P, Filliol D, Matifas A, Laustriat D, et al. (2006) Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc Natl Acad Sci U S A 103: 9691-9696. (Pubitemid 43955886)
25. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.
26. Martin M, Matifas A, Maldonado R, Kieffer BL (2003) Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones. Eur J Neurosci 17: 701-708. (Pubitemid 36315240)
27. Yamamoto J, Kawamata T, Niiyama Y, Omote K, Namiki A (2008) Down-regulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain. Neuroscience 151: 843-853.
28. Pradidarcheep W, Stallen J, Labruyere WT, Dabhoiwala NF, Michel MC, et al. (2009) Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors. Naunyn Schmiedebergs Arch Pharmacol 379: 397-402.
29. Couchman JR (2009) Commercial antibodies: the good, bad, and really ugly. J Histochem Cytochem 57: 7-8.
30. Michel MC, Wieland T, Tsujimoto G (2009) How reliable are G-protein-coupled receptor antibodies? Naunyn Schmiedebergs Arch Pharmacol 379: 385-388.
31. Li JL, Ding YQ, Li YQ, Li JS, Nomura S, et al. (1998) Immunocytochemical localization of mu-opioid receptor in primary afferent neurons containing substance P or calcitonin gene-related peptide. A light and electron microscope study in the rat. Brain Res 794: 347-352. (Pubitemid 28300472)
32. Wilson PO, Barber PC, Hamid QA, Power BF, Dhillon AP, et al. (1988) The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies. Br J Exp Pathol 69: 91-104.
33. Wang L, Hilliges M, Jernberg T, Wiegleb-Edstrom D, Johansson O (1990) Protein gene product 9.5-immunoreactive nerve fibres and cells in human skin. Cell Tissue Res 261: 25-33. (Pubitemid 20205948)
34. Jositsch G, Papadakis T, Haberberger RV, Wolff M, Wess J, et al. (2009) Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice. Naunyn Schmiedebergs Arch Pharmacol 379: 389-395.
35. Saper CB (2005) An open letter to our readers on the use of antibodies. J Comp Neurol 493: 477-478.
36. Burry RW (2011) Controls for immunocytochemistry: an update. J Histochem Cytochem 59: 6-12.
37. Wei LN (2011) The RNA superhighway: axonal RNA trafficking of kappa opioid receptor mRNA for neurite growth. Integr Biol (Camb) 3: 10-16.
38. Jung H, Yoon BC, Holt CE (2012) Axonal mRNA localization and local protein synthesis in nervous system assembly, maintenance and repair. Nat Rev Neurosci 13: 308-324.
39. Labuz D, Machelska H (2013) Stronger antinociceptive efficacy of opioids at the injured nerve trunk than at its peripheral terminals in neuropathic pain. J Pharmacol Exp Ther 346: 535-544.
40. Guan Y, Johanek LM, Hartke TV, Shim B, Tao YX, et al. (2008) Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury. Pain 138: 318-329.
41. Kayser V, Lee SH, Guilbaud G (1995) Evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in rats with peripheral mononeuropathy. Neuroscience 64: 537-545.
42. Rosen H, Abribat T (2005) The rise and rise of drug delivery. Nat Rev Drug Discov 4: 381-385. (Pubitemid 40704121)
43. Hua S, Cabot PJ (2013) Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition. Pain Physician 16: E199-216.